KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Times Interest Earned (2017 - 2025)

Biomarin Pharmaceutical's Times Interest Earned history spans 16 years, with the latest figure at -$16.06 for Q4 2025.

  • For the quarter ending Q4 2025, Times Interest Earned fell 125.64% year-over-year to -$16.06, compared with a TTM value of $37.57 through Dec 2025, down 1.72%, and an annual FY2025 reading of $37.57, down 1.72% over the prior year.
  • Times Interest Earned for Q4 2025 was -$16.06 at Biomarin Pharmaceutical, up from -$18.1 in the prior quarter.
  • The five-year high for Times Interest Earned was $103.35 in Q2 2025, with the low at -$18.1 in Q3 2025.
  • Average Times Interest Earned over 5 years is $18.74, with a median of $9.11 recorded in 2023.
  • Year-over-year, Times Interest Earned soared 1663.71% in 2023 and then crashed 147.18% in 2025.
  • Tracing BMRN's Times Interest Earned over 5 years: stood at -$17.13 in 2021, then surged by 78.93% to -$3.61 in 2022, then soared by 223.94% to $4.47 in 2023, then soared by 1300.13% to $62.63 in 2024, then tumbled by 125.64% to -$16.06 in 2025.
  • Per Business Quant, the three most recent readings for BMRN's Times Interest Earned are -$16.06 (Q4 2025), -$18.1 (Q3 2025), and $103.35 (Q2 2025).